December 26, 2025
The simulators market size is forecast to increase from USD 14.72 billion in 2026 to USD 25.53 billion by 2034...
Read MoreDecember 26, 2025
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 238.65 billi...
Read MoreDecember 26, 2025
The medical device CMO and CDMO market size is is set to grow significantly, driven by evolving consumer prefe...
Read MoreDecember 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreOctober 13, 2025
Projections indicate that, travel vaccination service industry is projected to rise from USD 4.69 billion in 2024 to USD 11.99 billion by 2034, reflecting a CAGR of 9.85% over the next decade. The rising prevalence of infectious disorders and increasing international travel bolster market growth. Favorable government support and a robust healthcare...
October 13, 2025
According to forecasts, the Europe cell and gene therapy market will grow from USD 2.74 billion in 2024 to USD 48.96 billion by 2034, with an expected CAGR of 23.90%. The Europe cell and gene therapy market is growing due to the growing incidence of genetic diseases and enhanced regulatory frameworks....
October 13, 2025
According to forecasts, the North America cell and gene therapy market will grow from USD 9.19 billion in 2024 to USD 79.01 billion by 2034, with an expected CAGR of 24.01%. The North America cell and gene therapy market is growing due to the rising demand for highly specific therapeutics for genetic disorders....
October 13, 2025
The cell and gene therapy infrastructure market is growing due to advances in gene editing technology and the increasing prevalence of genetic and chronic diseases. North America is dominant in the market due to the robust public and private spending....
October 13, 2025
The AI-based pharmaceutical R&D services market is growing due to rising demand for automation. North America’s dominance can be attributed to the rising R&D in developing novel therapeutics....
October 10, 2025
Projections indicate that, Middle East and Africa life science industry is projected to rise from USD 4.47 billion in 2024 to USD 13.07 billion by 2034, reflecting a CAGR of 11.32% over the next decade. The market is expanding due to rising R&D investments, technological advancements, and growing demand for precision medicine. In the Middle Eas...
October 10, 2025
Projections indicate that, the global Latin America life science market will increase from USD 4.49 billion in 2024 to USD 12.05 billion by 2034, experiencing a CAGR of 10.38% over the next 10 years. The market is expanding rapidly due to rising R&D investments, technological advancements, and growing demand for precision medicine and diagnosti...
October 10, 2025
According to market projections, the new chemical entities (NCE) CDMO sector is expected to grow from USD 2.65 billion in 2024 to USD 7.83 billion by 2034, reflecting a CAGR of 11.44%. The new chemical entities (NCE) CDMO market is growing due to its offering hope for managing diseases where existing therapies fall short or are inaccessible. North ...
October 10, 2025
Market insights predict the global Latin America pharmaceutical industry will increase from USD 91.85 billion in 2024 to USD 172.71 billion by 2034, achieving a CAGR of 6.52%. The market is expanding due to the rising prevalence of chronic diseases, increasing healthcare expenditure, and growing demand for innovative therapies. In Latin America, Br...
October 10, 2025
According to forecasts, the global myasthenia gravis treatment market will grow from USD 1.55 billion in 2024 to USD 3.29 billion by 2034, with an expected CAGR of 7.84%. The myasthenia gravis treatment market is growing due to the rising prevalence of myasthenia gravis (MG), the growing aging population, and enhanced diagnostic abilities. North Am...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com